Well said arlberg. l was listening to Doug Godshall on their latest webcast on Tuesday. He said they expected FDA approval later this year and he said it twice. Didn't like the sound of that when they were suggesting it should be coming about now.
FDA delays are a massive problem and are increasing. l believe funding and staffing are the issues. Considering they are dealing with saving lives and improving quality of life for literally millions across the US you would think some quick positive action would be taken.
HIN Price at posting:
$2.03 Sentiment: LT Buy Disclosure: Held